Will there be a successful human trial of a vaccine for rheumatoid arthritis by the end of 2028?
Gezondheid en geneeskundeOne-Off2j
Manifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 79.8%
Voorspellers
3
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 15 uur geleden
Verouderd22 mei 23, 01:52 UTC1 jan 29, 04:59 UTC
Trends
Regels
A team of researchers from the University of Toledo report that they were able to suppress the development of rheumatoid arthritis in rats by administering a vaccine containing the protein 14-3-3 zeta:
- https://www.thebrighterside.news/post/life-changing-vaccine-provides-long-lasting-protection-against-rheumatoid-arthritis
- The researchers have apparently filed for a patent for this concept and intend to pursue approval for early clinical trials in humans.
- Will their findings be reproduced in human trials?
- This will resolve YES if any clinical trial is performed to evaluate the efficacy of a vaccine for rheumatoid arthritis based on 14-3-3ζ before the end date, and the trial results show a statistically significant effect.
- Resolves NO otherwise.
